Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zebrafish 'able to repair spinal cord injuries'
In a cross section of the adult zebrafish spinal cord, stem cells (green) can be seen to divide (red and/or blue)
In a cross section of the adult zebrafish spinal cord, stem cells (green) can be seen to divide (red and/or blue).

Discovery may offer hope for new therapies in humans
 
Zebrafish are able to heal their own spinal cord injuries by growing new motor neurons, scientists have discovered.

It is hoped this finding could one day lead to new therapies for people with neurodegenerative conditions, such as motor neuron disease.

Damage to motor neurons in humans - either as a result of neurodegeneration or spinal cord injury - is irreversible.

Yet researchers from the University of Edinburgh found that serotonin - best known as the mood boosting hormone - can help zebrafish recover from spinal cord injuries.

They found the hormone is able to send signals to stem cells found in the spinal cord, boosting the growth of new motor neurons.

Using these findings, scientists say they may be able to grow motor neurons in the lab, aiding research into neurodegenerative conditions in humans.

Dr Thomas Becker, from Edinburgh's Centre for Neuroregeneration and the Euan MacDonald Centre for Motor Neuron Disease Research, said: "Understanding how zebrafish are able to repair damaged nerves could one day help us to trigger similar mechanisms in human stem cells.

"Our hope is that this may eventually lead to new treatments for conditions such as motor neuron disease, for which there is no cure."

Image (c) Catherina Becker, University of Edinburgh.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.